Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Btc Diagnostics, Inc. — Predicate Candidate Screening

5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

102 daysmedian FDA review time
225 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K841545ENZYME IMMUNOASSAY FOR DETECTION HORMBtc Diagnostics, Inc.1984-11-272250
K832905QUALITATIVE ENZYME IMMUNOASSAY-DETECTBtc Diagnostics, Inc.1984-02-031580
K833710BTC URINE LH ASSAYBtc Diagnostics, Inc.1984-01-301020
K831604HCG ACCU-STICKBtc Diagnostics, Inc.1983-07-19620
K831125BTC URINE LCG ASSAYBtc Diagnostics, Inc.1983-05-05300

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda